N. Thatcher

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Mark R. Middleton, Jean‐Jacques Grob, Neil K. Aaronson et al. · Journal of Clinical Oncology · 2000 · 1.3K citations

Pharmacy, Oncology, Pharmacokinetics +12

Alternate splicing produces a novel cyclin D1 transcript.

DC Betticher, N. Thatcher, H. J. Altermatt et al. · PubMed · 1995 · 399 citations

Life Sciences, Genetics, Molecular Biology +7

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Heather Anderson, Birthe Lund, Flemming W. Bach et al. · Journal of Clinical Oncology · 1994 · 376 citations

Medicine, Oncology, Pharmacology +15

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.

N. M. Bleehen, E.S. Newlands, Siow Ming Lee et al. · Journal of Clinical Oncology · 1995 · 284 citations

Medicine, Oncology, Pharmacology +16

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

B. W. Hancock, Keith Wheatley, SyedHasan Harris et al. · Journal of Clinical Oncology · 2003 · 228 citations · Full text

Medicine, Oncology, Pharmacotherapy +16